HIV/AIDS: Latest MSF Updates
- MSF Survey Shows High Viral Load in Men and People with CD4 500-75
- Beyond the Rhetoric: Implement Proven Community Strategies to Fight HIV/AIDS
- World AIDS Day Portraits: My Life in My Hands
- Fighting HIV and Stigma in Epworth, Zimbabwe
Since its discovery in 1981, HIV/AIDS has killed more than 25 million people. If left untreated, HIV gradually weakens the body’s immune system, usually over a period of up to 10 years after infection.
At the end of 2013, MSF had 341,645 HIV patients registered under our care and 325,500 patients on first-line antiretroviral treatment.
A person living with HIV is considered to have developed AIDS when their immune system is so weak it can no longer fight off certain opportunistic infections and diseases, such as pneumonia, meningitis, and some cancers. One of the most common opportunistic infections among people living with HIV/AIDS is tuberculosis (TB).
According to the World Health Organization, there are more than 34 million people living with HIV/AIDS worldwide, the majority of them in sub-Saharan Africa.
One tenth of HIV/AIDS sufferers are children (3.4 million) under the age of 15, with over 1,000 becoming infected every day.
Without treatment, half of all infants with HIV will die before their second birthday.
What Causes HIV/AIDS?
HIV is most commonly spread by sexual activities and the exchange of body fluids.
It can also be transmitted through childbirth, breastfeeding, and sharing needles.
Symptoms of HIV/AIDS
While some people may develop symptoms similar to flu within the first two to six weeks of catching the virus, others may not show symptoms for many years while the virus slowly replicates.
Once the initial flu-like symptoms disappear, HIV will not show any further symptoms for many years.
Despite the availability of affordable rapid tests for HIV, knowledge of HIV status remains low in sub-Saharan Africa where HIV prevalence is highest.
An estimated 60 percent of people living with HIV are unaware of their status and in some settings this figure is far lower; a study in Kenya in 2009, for example, found that only 16 percent of HIV-infected adults knew that they were infected.
There is no cure for HIV/AIDS, although treatments are much more successful than they used to be. A combination of drugs, known as antiretrovirals (ARVs), help combat the virus and enable people to live longer, healthier lives without their immune system rapidly declining.
MSF HIV/AIDS programs offer HIV testing with pre- and post-test counseling, treatment and prevention of opportunistic infections, prevention of mother-to-child transmission, and provision of ARVs for people in the late stages of the disease.
Our programs also generally include support to prevention, education, and awareness activities to help people understand how to prevent the spread of the virus.
At the end of 2013, we had 341,645 HIV patients registered under our care and 325,500 patients on first-line antiretroviral treatment.
This page was last updated on October 6, 2014.
The MSF Access Campaign works to improve access to medicines and stimulate the development of urgently needed treatments. MSF Access Campaign.
An archive of MSF's scientific articles available free, with full text and in an easily searchable format. MSF Field Research website.
In 2003, seven organizations from around the world joined forces to establish DNDi, Drugs for Neglected Diseases Initiative.